Cartesian Therapeutics Inc (NAS:RNAC)
$ 18.83 0.92 (5.14%) Market Cap: 478.56 Mil Enterprise Value: 274.02 Mil PE Ratio: 0 PB Ratio: 607.42 GF Score: 52/100

Selecta Biosciences Inc Annual Shareholders Meeting Transcript

Jun 14, 2019 / 01:00PM GMT
Release Date Price: $63 (-2.33%)
Operator

Good morning, everyone, and welcome to Selecta Biosciences, Inc. Annual Meeting of Stockholders. I would now like to turn the conference over to Carsten Brunn, President and Chief Executive Officer. Please go ahead.

Carsten Brunn
Selecta Biosciences, Inc. - CEO, President & Director

Thank you. Good morning, ladies and gentlemen. Carsten Brunn, President and CEO of Selecta. I would like to welcome you all to our 2019 Annual Meeting of Stockholders and thank you for your ongoing support of Selecta Biosciences.

I also want to thank the members of the Board and management who are with us today. I'll act as the Chairman of this meeting, and Elona Kogan, our General Counsel, will act as secretary. The other members of the Board who are here with us today are Tim Barabe, Omid Farokhzad, Amir Nashat, Aymeric Sallin, Tim Springer and Pat Zenner. I would also like to introduce Jason Janoff and Peter Catalano of Ernst & Young, the company's independent Auditor, who'll be available to respond to appropriate questions via the Ask a Question box found on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot